ATLANTA--(BUSINESS WIRE)-- Holzer & Holzer, LLC is investigating whether MabVax Therapeutics Holdings, Inc. (“MabVax” or the “Company”) (NASDAQ: MBVX) complied with the federal securities laws. On January 30, 2018, MabVax announced that it received notice that the Securities and Exchange Commission (“SEC”) is investigating and examining certain of the Company’s filed registration statements and subsequent amendments. The price of MabVax stock fell significantly following the announcement. If you purchased MabVax common stock ...
NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of purchasers of the securities of MabVax Therapeutics Holdings, Inc. (NASDAQ: MBVX) resulting from allegations that MabVax may have issued materially misleading business information to the investing public. On January 30, 2018, MabVax announced “that it received notice that the Securities and Exchange Commission (“SEC”) was conducting an investigation and examination pursuant to S...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.